Bridgebio Oncology Therapeutics Inc (BBOT)

May 23, 2026

BridgeBio Oncology Therapeutics Inc. (BBOT) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Stem Stock SlideProfit Announcement - Newser

May 23, 2026

May 22, 2026

BBOT Dips Close to Lows With One Cancer Drug Update Steering Trade - Bez Kabli

May 22, 2026

May 21, 2026

BBOT SEC FilingsBridgeBio Oncology Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 21, 2026

May 14, 2026

BridgeBio Oncology’s New ERP Rollout Poses Significant Operational and Reporting Risks - TipRanks

May 14, 2026

May 13, 2026

BridgeBio Oncology Therapeutics (BBOT) registers 63.05M shares for resale — supplement adds Q1 2026 10-Q - Stock Titan

May 13, 2026

May 13, 2026

BridgeBio Oncology Therapeutics, Inc.Common Stock (Nasdaq:BBOT) Stock Quote - FinancialContent

May 13, 2026

May 13, 2026

BridgeBio Oncology Therapeutics (BBOT) Reports Q1 2026 Results: Positive RAS-Pathway Cancer Drug Data, Cash Runway Into 2028 - Minichart

May 13, 2026

May 12, 2026

BridgeBio Oncology as of March 31 Cash, Cash Equivalents and Marketable Securities Totaling $388.9M >BBOT - Moomoo

May 12, 2026

May 12, 2026

BridgeBio Oncology Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2026

May 12, 2026

Bbot reports first quarter 2026 financial results and update on corporate progress - marketscreener.com

May 12, 2026

May 12, 2026

BridgeBio Oncology Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

May 12, 2026

May 12, 2026

BridgeBio Oncology Therapeutics 1Q 2026: Net loss $(42.1M), EPS $(526.11) — 10-Q Summary - TradingView

May 12, 2026

May 12, 2026

[10-Q] BridgeBio Oncology Therapeutics, Inc. Quarterly Earnings Report - Stock Titan

May 12, 2026

May 12, 2026

BridgeBio Oncology Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 12, 2026

May 12, 2026

BridgeBio Oncology (Nasdaq: BBOT) widens Q1 2026 loss while advancing RAS-pathway cancer programs - Stock Titan

May 12, 2026

May 12, 2026

BridgeBio Oncology Thera 1Q Loss/Shr $526.11 >BBOT - Moomoo

May 12, 2026

May 12, 2026

BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewswire

May 12, 2026

May 12, 2026

Cancer drug trials show tumor shrinkage as BBOT funds work into 2028 - Stock Titan

May 12, 2026

May 12, 2026

BridgeBio Oncology (BBOT) grants COO 758,222 stock options - Stock Titan

May 12, 2026

May 12, 2026

BridgeBio Oncology CEO granted 1,103,837 options | BBOT Insider Trading - Stock Titan

May 12, 2026

May 12, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 12, 2026

May 12, 2026

This Arxis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm

May 12, 2026

May 12, 2026

A Quick Look at Today's Ratings for BridgeBio Oncology Therapeutics(BBOT.US), With a Forecast Between $21 to $41 - Moomoo

May 12, 2026

May 12, 2026

BridgeBio Oncology Price Target Announced at $23.00/Share by Canaccord Genuity - Moomoo

May 12, 2026

May 11, 2026

BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

May 11, 2026

May 11, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

May 11, 2026

May 07, 2026

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sets New 52-Week LowTime to Sell? - MarketBeat

May 07, 2026

May 05, 2026

BridgeBio Oncology Therapeutics (BBOT) officer has 1,047 shares withheld for RSU tax - Stock Titan

May 05, 2026

May 05, 2026

BridgeBio Oncology (BBOT) CEO has RSU shares withheld to cover taxes - Stock Titan

May 05, 2026

May 05, 2026

Tax withholding trims BridgeBio Oncology (BBOT) insider holdings slightly - Stock Titan

May 05, 2026

May 05, 2026

[EFFECT] BridgeBio Oncology Therapeutics, Inc. SEC Filing - Stock Titan

May 05, 2026

May 04, 2026

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Stock Price Today & Analysis - Gotrade

May 04, 2026

Apr 30, 2026

BBOT (NASDAQ: BBOT) registers 63.05M common shares for resale - Stock Titan

Apr 30, 2026

Apr 30, 2026

BridgeBio Oncology (NASDAQ: BBOT) accounting chief reports initial equity stake - Stock Titan

Apr 30, 2026

Apr 30, 2026

BridgeBio Oncology (NASDAQ: BBOT) COO Idan details initial stock and option holdings - Stock Titan

Apr 30, 2026

Apr 30, 2026

The Escalator: BridgeBio Oncology Therapeutics, Haleon, AstraZeneca and more - Medical Marketing and Media

Apr 30, 2026

Apr 29, 2026

63.05M shares registered; CEO change and consulting deal at BridgeBio Oncology (BBOT) - Stock Titan

Apr 29, 2026

Apr 29, 2026

Ex-CEO Wallace stays advisor at BridgeBio Oncology (BBOT) - Stock Titan

Apr 29, 2026

Apr 28, 2026

[ARS] BridgeBio Oncology Therapeutics, Inc. SEC Filing - Stock Titan

Apr 28, 2026

Apr 28, 2026

BridgeBio Oncology (Nasdaq: BBOT) details 2026 virtual meeting, board elections and auditor - Stock Titan

Apr 28, 2026

Apr 28, 2026

BridgeBio Oncology Therapeutics appoints new CEO and COO - MSN

Apr 28, 2026

Apr 27, 2026

BridgeBio Oncology (BBOT) Stock News, Page 3 - Stock Titan

Apr 27, 2026

Apr 27, 2026

BridgeBio Oncology rises on Fast Track status for pancreatic cancer asset - MSN

Apr 27, 2026

Apr 24, 2026

H.C. Wainwright reiterates BridgeBio Oncology stock rating at buy By Investing.com - Investing.com India

Apr 24, 2026

Apr 24, 2026

H.C. Wainwright reiterates BridgeBio Oncology stock rating at buy - Investing.com

Apr 24, 2026

Apr 23, 2026

Stifel Maintains BridgeBio Oncology Therapeutics(BBOT.US) With Buy Rating, Maintains Target Price $23 - Moomoo

Apr 23, 2026

Apr 23, 2026

BridgeBio (BBOT) Stock: Price Pattern Formation | Q4 2025: EPS Beats ForecastsDividend Growth Rate - Xã Thanh Hà

Apr 23, 2026

Apr 23, 2026

BridgeBio Oncology Overhauls Leadership for Next Development Phase - TipRanks

Apr 23, 2026

Apr 23, 2026

BridgeBio Oncology names Pedro Beltran as new CEO By Investing.com - Investing.com India

Apr 23, 2026